Presently, Andreas Fibig occupies the position of Chairman of Max Planck Institute For Infection Biology and Chairman & Chief Executive Officer at International Flavors & Fragrances, Inc.
He is also on the board of Novo Nordisk A, World Business Council for Sustainable Development, European Federation of Pharmaceutical Industries & Assns and Verband Forschender Arzneimittelhersteller e.V. and Member of German Academy of New York and Member of German American Chamber of Commerce, Inc.
In the past Andreas Fibig held the position of Senior VP-US Pharmaceutical Operations Group at Pfizer Inc. and President-Market at Pharmacia GmbH (a subsidiary of Pfizer Inc.), Chairman & President at Bayer HealthCare Pharmaceuticals, Inc., Chairman for Bayer Pharma AG, Principal at Boehringer Ingelheim GmbH and Director-Sales & Marketing at Bayer Schering Pharma AG.
He received an undergraduate degree from Hochschule für Wirtschaft und Recht Berlin.